Literature DB >> 9167173

Melanosomal proteins as melanoma-specific immune targets.

C Sakai1, Y Kawakami, L W Law, M Furumura, V J Hearing.   

Abstract

Pigmentation of our skin, hair and eyes is essential for photoprotection, embryological development, detoxification and protective/cosmetic coloration. A number of proteins important to the production of melanin within melanosomes have now been identified including enzymatic and structural proteins encoded at the murine albino, brown, pinkeyed-dilution, MART1, slaty and silver loci. Interestingly, many of those melanosomal proteins (including epitopes derived from tyrosinase, TRP1/gp75, silver/gp100 and MART1/melan-A) function in vivo as targets of humoral and cellular autoimmune responses directed specifically against normal or transformed melanocytes. These findings have provided new impetus to research on immune responses to melanoma and, perhaps more importantly, examining why they are insufficient to provide protection against tumour growth and what type of immune therapy can be designed to correct that. The melanosome must now be considered beyond its function in pigmentation, and assumes the role of a valuable source for specific immune targets for malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9167173     DOI: 10.1097/00008390-199704000-00001

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  10 in total

Review 1.  Feasibility of immunotherapy for lymphangioleiomyomatosis.

Authors:  Michele Carbone
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

2.  Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.

Authors:  Jeffrey A Mosenson; Kelsey Flood; Jared Klarquist; Jonathan M Eby; Amy Koshoffer; Raymond E Boissy; Andreas Overbeck; Rebecca C Tung; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-13       Impact factor: 4.693

3.  Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes.

Authors:  Kevin G Chen; Gergely Szakács; Jean-Philippe Annereau; Francois Rouzaud; Xing-Jie Liang; Julio C Valencia; Chandrasekharam N Nagineni; John J Hooks; Vincent J Hearing; Michael M Gottesman
Journal:  Pigment Cell Res       Date:  2005-04

4.  Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.

Authors:  I Caroline Le Poole; Adam I Riker; M Eugenia Quevedo; Lawrence S Stennett; Ena Wang; Francesco M Marincola; W Martin Kast; June K Robinson; Brian J Nickoloff
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 5.  Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity.

Authors:  Michael S Marks; Alexander C Theos; Graça Raposo
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization.

Authors:  D R Surman; K R Irvine; E P Shulman; T M Allweis; S A Rosenberg; N P Restifo
Journal:  J Immunol Methods       Date:  1998-05-01       Impact factor: 2.303

7.  Coupling and uncoupling of tumor immunity and autoimmunity.

Authors:  W B Bowne; R Srinivasan; J D Wolchok; W G Hawkins; N E Blachere; R Dyall; J J Lewis; A N Houghton
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

8.  Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.

Authors:  Randal K Gregg; Lisa Nichols; Yiming Chen; Bao Lu; Victor H Engelhard
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  A quantitative increase in regulatory T cells controls development of vitiligo.

Authors:  Shilpak Chatterjee; Jonathan M Eby; Amir A Al-Khami; Myroslawa Soloshchenko; Hee-Kap Kang; Navtej Kaur; Osama S Naga; Anuradha Murali; Michael I Nishimura; I Caroline Le Poole; Shikhar Mehrotra
Journal:  J Invest Dermatol       Date:  2013-12-23       Impact factor: 8.551

10.  Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.

Authors:  Joan Anton Puig-Butille; María José Escámez; Francisco Garcia-Garcia; Gemma Tell-Marti; Àngels Fabra; Lucía Martínez-Santamaría; Celia Badenas; Paula Aguilera; Marta Pevida; Joaquín Dopazo; Marcela del Río; Susana Puig
Journal:  Oncotarget       Date:  2014-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.